Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

The Human Genome Project’s working draft sequence, which was completed to much fanfare in June 2000, took about a dozen years and more than $300 million to complete. The result was a composite map of the DNA from several people-a sort of averaged genetic picture of a human. But a growing number of companies are working on advanced technologies that could make it possible to have your own individual genome sequenced in a day, perhaps for as little as a few thousand dollars.

No one’s genetic makeup matches “the human genome” exactly; the differences are what give one person brown eyes and another blue or make some people more susceptible to heart disease. The new technologies could give anyone access to the unique, letter-by-letter sequence of his or her entire genome and help doctors detect the variations that signal health problems down the road.

Today’s sequencing methods are costly and slow in part because for each DNA letter read-of the roughly three billion in a human genome-researchers need to synthesize a separate copy of the DNA strand. Making the copies requires several chemical reactions; then you have to separate and identify the newly made strands. In contrast, two new techniques being developed could read the sequence directly from one DNA molecule. The first method, called “nanopore sequencing,” involves pushing a strand of DNA through a tiny hole surrounded by sensors that detect the electrical changes caused by each DNA letter. The second takes advantage of an enzyme called DNA polymerase, which copies DNA inside our cells. Researchers use specialized optics to detect each letter added as the enzyme copies the original DNA strand.

In May, Palo Alto, CA-based Agilent Technologies signed an agreement with Harvard researchers Daniel Branton and Jene Golovchenko to further develop nanopore sequencing, which Branton coinvented (see “Hole in the Wall Offers Cheaper Sequencing,” TR May/June 1998). Also this year, Woburn, MA-based U.S. Genomics received its first patents on technologies that combine the two direct techniques. Thanks to these and several other efforts (see table), the dream of sequencing a human genome in just a day could be a reality in two to five years, says George Weinstock, codirector of the Baylor College of Medicine Human Genome Sequencing Center in Houston. “They’re all very clever techniques,” he says. “We’re getting very close to having them in hand.”

Though the new sequencing tools will initially be used for biomedical research, they could eventually find their way into doctors’ offices, not only providing for quick gene-based diagnosis of a host of diseases, but also helping doctors choose medicines tailored to individual patients. The expected price tag to sequence your genome-perhaps $5,000 to $30,000-might seem steep, but “it’s kind of a life investment,” says Harvard Medical School biophysicist George Church. “I would pay $10,000 to get my genome sequencedrather than buying a second car.”

0 comments about this story. Start the discussion »

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me